Sunwin Stevia International, Inc. Reports Earnings Results for the Second Quarter Ended October 31, 2019
December 16, 2019 at 10:02 pm
Share
Sunwin Stevia International, Inc. announced earnings results for the second quarter ended October 31, 2019. For the second quarter, the company announced total revenue was USD 7.161 million compared to USD 4.885 million a year ago. Operating income was USD 350,532 compared to operating loss of USD 864,943 a year ago. Net income was USD 191,891 compared to net loss of USD 1.105 million a year ago. For the half year, total revenue was USD 14.051 million compared to USD 9.882 million a year ago. Operating income was USD 388,394 compared to operating loss of USD 1.781 million a year ago. Net loss was USD 191,344 compared to USD 2.295 million a year ago.
Sunwin Stevia International, Inc. sells stevioside, a natural sweetener, and herbs used in traditional Chinese medicines and veterinary products. The Company operates through two segments related to its product lines: Stevioside, which produces and sells a range of purified steviol glycosides with rebaudioside A and stevioside as the principal components; a natural, low calorie sweetener, and OnlySweet, a stevioside-based table top sweetener, and Chinese medicines, which manufactures and sells traditional Chinese medicine formula extracts, which are used in products made for use by both humans and animals. The Company engages in new product development both through its internal research facilities, industry consultants and specialists to provide research and development for the planting of stevia plants, for the development of biological methods to improve lower-grade stevia product to higher-grade stevia, and for the application of biological method to change the taste of stevia.
SUNWIN STEVIA INTERNATIONAL, INC. 
